Pulse Biosciences, Inc. (PLSE) Reports Q3 Loss of $0.64

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. DASH
9. MA
10. FND

Go back to Pulse Biosciences, Inc. (PLSE) Reports Q3 Loss of $0.64

Pulse Biosciences Quarterly Investor Conference Call

October 30, 2018 4:03 PM EDT

Conference call today at 1:30 p.m. PDT / 4:30 p.m. EDT

HAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel medical therapy company bringing to market its proprietary Nano-Pulse Stimulation (NPS) platform, today reported recent corporate developments and financial results for the three- and nine-month periods ended September 30, 2018.

Recent Developments

Completion of enrollment and patient treatments in the Companys NPS clinical study for the treatment of Sebaceous Hyperplasia (SH) Study enrollment and patient... More